Botswana Vaccine Institute

What Botswana Vaccine Institute does

Botswana Vaccine Institute (BVI) is a veterinary vaccine manufacturer founded in 1979 and headquartered in Gaborone, Botswana, with approximately 99 employees. The institute develops, manufactures, and distributes vaccines for livestock species including cattle, sheep, goats, and poultry, as well as companion animals, targeting common and transboundary animal diseases relevant to Southern Africa. Its underlying technology combines traditional vaccine manufacturing with modern biotechnology methods — genetics, molecular biology, and advanced laboratory procedures — supported by quality control systems and field-validated development processes.

BVI generates revenue through vaccine product sales and government contracts tied to national livestock disease control and vaccination programs. Its distribution model is channel-mediated: government agricultural ministries serve as the primary institutional buyer and channel for national campaigns, while agricultural cooperatives and veterinary clinics extend reach into rural smallholder farms and commercial livestock operations across Southern Africa. Pricing is not publicly disclosed and appears to flow through government subsidy programs and veterinary distribution networks rather than direct market transactions.

The institute positions itself as a continental leader in animal disease control, with a stated commitment to food security and sustainable agriculture in the region. It serves three primary customer segments — livestock farmers (primary), government agricultural agencies, and veterinary practitioners — and is associated with Boehringer Ingelheim in the context of veterinary pharmaceutical research collaboration. Note: a domain scraped under bvi-bw.com contains unrelated Japanese-language content about government benefit programs and does not represent BVI's corporate operations.

Name

Botswana Vaccine Institute

Website

https://bvi-bw.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Botswana Vaccine Institute is a Gaborone-based veterinary vaccine manufacturer founded in 1979 that develops and supplies livestock and companion animal vaccines across Southern Africa through government, cooperative, and veterinary distribution channels.

Ownership category

akta.pro rank

Product category

Veterinary Vaccines

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Veterinary Vaccines (HLAIAEAH), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM)

Keywords

• Veterinary vaccine manufacturing
• Livestock disease prevention
• Animal health biologicals
• Livestock vaccination programs
• Agricultural biotechnology

Headquarters

HQ city

Gaborone

HQ country

Botswana

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain, Infrastructure

Revenue model

1. Vaccine Product Sales: Sale of veterinary vaccines and biologicals to livestock farmers, government agencies, and veterinary distributors across Southern Africa.
2. Government Contracts: Partnerships with government ministries and agricultural departments for national livestock disease control and vaccination programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

BVI develops and manufactures veterinary vaccines and biologicals for livestock (cattle, sheep, goats, poultry) and companion animals. Products are produced using biotechnology methods, rigorous quality control, and field-validated processes, and are distributed via government agricultural ministries, farming cooperatives, and veterinary practitioner networks across Southern Africa. The institute also supports national livestock disease control and vaccination programs.

Product overview

No specific product portfolio or named offerings for the Botswana Vaccine Institute were identified in the available source content. The sources contain general informational articles about animal health, livestock vaccination, and agricultural biotechnology topics, but no distinct branded products, modules, or named service offerings are described for BVI.

Differentiator

Problem solved

Functional benefit

Products and services

• Livestock vaccines (cattle, sheep, goats, poultry) Veterinary vaccines developed and manufactured to protect cattle, sheep, goats, and poultry from common and transboundary animal diseases, sold to livestock farmers, government agencies, and veterinary distributors across Southern Africa.
• National livestock vaccination program supply Bulk supply of veterinary vaccines through government ministries to support national livestock disease control programs and protect the beef export industry.

Quantifiable outcome

• Livestock disease prevention leading to improved farm productivity and reduced mortality rates

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Virbac: Animal health pharmaceutical company producing vaccines, parasiticides, and nutrition products. Comparable in livestock vaccine category though broader portfolio and global reach versus BVI's regional focus.
• Phibro Animal Health: Diversified animal health and mineral nutrition company with livestock vaccine products. Comparable in livestock health products category though Phibro is more diversified across nutritional and pharmaceutical categories.
• MSD Animal Health (Merck Animal Health): Global animal health division of Merck producing vaccines, anti-infectives, and parasiticides for livestock. Comparable in livestock vaccine category though operates globally rather than regionally focused like BVI.
• Elanco Animal Health: Global animal health company offering vaccines, parasiticides, and therapeutic products for livestock and companion animals. Overlaps with BVI in livestock vaccines but serves broader portfolio globally.
• Zoetis: Global leader in animal health and veterinary pharmaceuticals including vaccines for livestock and companion animals. Direct overlap with BVI in livestock vaccine manufacturing but operates at vastly larger scale across multiple geographies.
• Vetoquinol: Independent veterinary pharmaceutical company producing vaccines and medicines primarily for livestock and companion animals. Overlaps with BVI in livestock veterinary biologicals, though focused on European and North American markets.

Direct peers

• Ceva Santé Animale: Multinational veterinary pharmaceutical and vaccine company with strong presence in emerging markets and Africa. Competes directly with BVI in livestock vaccines for cattle, poultry, and small ruminants.
• Boehringer Ingelheim Animal Health: Major animal health division with extensive livestock vaccine portfolio. Identified as a collaboration partner for BVI and competes in the same veterinary vaccine category serving African and emerging markets.

Emerging players

• Hester Biosciences: Indian veterinary vaccine and animal health products manufacturer focused on poultry and livestock vaccines. Comparable regional emerging-market veterinary vaccine producer serving smallholder farmers and government programs.
• Indian Immunologicals: Veterinary vaccine manufacturer in India producing livestock and human vaccines. Comparable to BVI as a regional public-sector-affiliated veterinary biologicals producer targeting livestock disease control in emerging markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/botswana-vaccine-institute

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Botswana Vaccine Institute